26-05-2025
Dietary supplements containing drugs recalled due to serious health risks
Umary USA announced a voluntary recall of dietary supplements marketed nationwide for joint pain and arthritis relief as they contain drugs that pose serious health risks, according to the U.S. Food and Drug Administration.
All lots and dates of the supplements, Unavy Ácido Hialurónico and Umovy Ácido Hialurónico caplets, are covered by the recall. Consumers who purchased the supplements should immediately stop taking them and consult their health care provider for safe discontinuation of use.
The caplets contain the undeclared drugs diclofenac, dexamethasone and omeprazole, according to the FDA. Because they contain those drugs, they cannot be marketed as dietary supplements. Their safety and effectiveness have not been established, according to the FDA.
'Dexamethasone, a corticosteroid, can weaken the immune system, cause high blood sugar, muscle damage, psychiatric effects and cardiovascular problems,' the FDA press release states. 'Prolonged or high-dose use may suppress adrenal gland function and abrupt stopping can lead to withdrawal symptoms.'
'Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), may cause severe cardiovascular, gastrointestinal, kidney, and allergic reactions, especially in patients taking other NSAIDs or blood thinners or those with allergies or underlying health issues,' the statement reads.
'Omeprazole, a proton pump inhibitor used to treat stomach acid disorders, might mask serious gastric conditions such as ulcers or cancer if taken unknowingly,' the statement reads.
Unavy Ácido Hialurónico comes in a white plastic bottle with a black label marked with white and yellow text. Umovy Ácido Hialurónico is packaged in a black plastic bottle with a black label featuring white and blue lettering. Both products come in 30-count, 850-mg caplets.
The supplements were distributed nationwide by Umary USA, which is notifying distributors and customers by press release and email. The company is arranging for returns and refunds, according to the FDA.
There have been no reported adverse reactions linked to using the two products. Consumers who are experiencing problems related to the caplets should contact their healthcare provider and report issues to the FDA's MedWatch program online.
For questions about the recall, consumers can contact Umary USA at umaryusa2025@ available 24/7.
For more information, visit the official FDA recall notice here.
Multi-state salmonella outbreak linked to recalled cucumbers
Public health alert: Listeria found in Big Y, Price Chopper ready-to-eat wrap
Tattoo ink recalled due to contamination with infection-causing microorganisms
Read the original article on MassLive.